Coming up: SGLT2s to reduce cardiovascular death in T2D

4 minute read


Two thirds of all deaths in patients with type 2 diabetes are from cardiovascular disease.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×